Dr. Maddala’s experience in the development and evaluation of drug and genomic diagnostic products will benefit our clients, especially those developing therapies for indications in oncology.
ROCHELLE, Va. (PRWEB)
April 24, 2019
NDA Partners Chairman Carl Peck, MD, announced today that Tara Maddala, PhD, a biostatistician with more than 20 years of experience in the development of drug and genomic diagnostic products for therapeutic indications in oncology, has joined the firm as an Expert Consultant.
Prior to joining NDA Partners, Dr. Maddala served as Vice President of Biometrics at GRAIL, Inc., where she built and led a multidisciplinary team responsible for study design, biosample and data management operations, and analysis and reporting of clinical genomic studies. Before GRAIL, as Senior Director of Biostatistics at Genomic Health, Inc., she led the team responsible for the design and analysis of large-scale oncology biomarker studies that resulted in algorithm-based commercial diagnostics. Earlier in her career, as Director of Biostatistics at Clinimetrics Research Associates, Inc., she led a statistics team that supported clinical trials for pharmaceutical and biotechnology companies.
“Dr. Maddala’s experience in the development and evaluation of drug and genomic diagnostic products will benefit our clients, especially those developing therapies for indications in oncology,” said Dr. Peck. “We are pleased to welcome her to NDA Partners.”
Dr. Maddala received her Doctorate in Biostatistics from the University of Texas, Master’s degree in Health Systems Engineering from The Georgia Institute of Technology, and Bachelor’s degree in Industrial and Systems Engineering from The University of Florida. She is a co-inventor on several genomic diagnostic patents, has co-authored approximately 20 peer-reviewed publications and more than 30 congress presentations, and is a lecturer for the University of California, Berkeley/University of California, San Francisco Master’s in Translational Medicine Program.
About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.
Earle Martin, Chief Executive Officer